Infusion Pump Ransomware: Step-by-Step Data Incident Response Checklist

Infusion pump ransomware threatens both therapy continuity and sensitive data. Use this checklist to protect patients first, contain the threat, preserve evidence for Ransomware Forensics, and return devices to safe operation within a robust Medical Device Cybersecurity program.

Identify Affected Devices

Quickly determine which pumps and supporting systems show compromise indicators so you can focus containment and care. Build an accurate scope before making configuration changes.

Immediate actions

• Activate incident command and assign clinical engineering, security, and nursing leads with clear roles and time-stamped tasks.
• Verify on-device symptoms: ransom messages, locked screens, unexpected alarms, or unexplained rate changes reported by bedside staff.
• Correlate with integration systems: pump gateways, EHR interfaces, and medication library servers for offline errors or unusual queues.
• Consult the asset inventory/CMMS to enumerate models, firmware versions, network details, and current physical locations.
• Expand scope to “potentially affected” devices of the same model or network segment until proven safe through triage.

Record the following

• Device model, serial number, firmware, hostname, IP/MAC, subnet/VLAN, and physical location.
• Patient identifier, therapy type, current infusion status, battery level, and last reboot time.
• First observed time, screenshots/photos of messages, and the staff member who observed the issue.

Isolate Infected Infusion Pumps

Containment must never jeopardize care. Apply Incident Containment Strategies that prioritize Patient Safety Protocols, then restrict device communications to prevent spread.

Clinical isolation (Patient Safety Protocols first)

• Coordinate with the bedside clinician to transition therapy to a safe alternative device or method before removing a pump from service.
• If therapy is stable, keep the pump running only until handoff is complete; if behavior is unsafe or erratic, stop per clinical judgment and remove immediately.
• Affix “Do Not Use — Under Forensic Hold” labeling and relocate the device to a secure area after patient decoupling.

Technical isolation (Incident Containment Strategies)

• Physically disconnect Ethernet and disable Wi‑Fi; block the device at access points and switches; quarantine in a restricted area.
• Enforce Network Segmentation: move suspected devices to a quarantine VLAN, block east‑west traffic, and restrict to only vetted management endpoints.
• Update NAC to deny by MAC, and apply egress filtering to prevent command‑and‑control or data exfiltration.
• Disable nonessential remote services; avoid inserting removable media or unknown peripherals.

Avoid

• Do not factory reset, wipe, or patch before evidence preservation unless required for immediate patient safety.
• Avoid powering off unless the device threatens safety or you have explicit direction from clinical leadership or the manufacturer.

Preserve Evidence and Logs

Effective Ransomware Forensics supports root-cause analysis, recovery, and any required reporting. Protect integrity and maintain a clear chain of custody.

Collect

• Photograph ransom notes, lock screens, error codes, and pump status indicators with visible timestamps.
• Export device event logs using manufacturer procedures; collect gateway, interface engine, and related server logs.
• Gather security telemetry: firewall, proxy, DNS, DHCP, WLAN controller, NAC, and SIEM records for the relevant time window.
• For management hosts, acquire forensic images; note any file extensions, ransom IDs, or artifacts observed.

Protect

• Store evidence on write-once/offline media; compute and record cryptographic hashes; document handlers and timestamps (chain of custody).
• If supported and safe, capture volatile data per manufacturer guidance; freeze backup cycles to avoid overwriting useful snapshots.
• Perform Data Integrity Verification: compare EHR orders, medication libraries, and device logs; validate file and firmware checksums.

Notify Stakeholders

Clear, timely communication limits harm and aligns clinical, technical, and legal actions. Prepare factual updates and avoid sharing unnecessary sensitive data.

Internal stakeholders

• Incident command, security leadership, clinical engineering, nursing and pharmacy leadership, privacy/legal, risk management, and communications.

External partners

• Device manufacturers, service providers, managed security partners, cyber insurance contacts, and appropriate law enforcement.

Regulatory Compliance Notifications

• Evaluate and execute required notifications to applicable privacy and safety regulators, along with any contractual partner notifications.
• Track deadlines, content requirements, and acknowledgments; maintain proof of submission for audits.

Assess Patient and Data Impact

Your risk assessment drives care decisions and reporting. Examine both therapy outcomes and information risk across affected systems.

Patient safety assessment

• Identify all patients connected to affected devices; review therapy logs for pauses, rate deviations, or alarms.
• Reconcile delivered doses against orders using EHR and bedside documentation; escalate variances for clinical review.
• Monitor for potential adverse events and document any treatment modifications and timing.

Data scope and integrity

• Determine what data the pumps, gateways, and related servers store or transmit, including sensitive identifiers or therapy details.
• Review telemetry for exfiltration attempts and staging activity; confirm whether data left the environment.
• Perform Data Integrity Verification of medication libraries, orders, and device events; document breach determinations and rationale.

Implement Recovery Procedures

Recover methodically to avoid re‑infection and to strengthen long‑term resilience. Validate every step before devices return to patient care.

Device remediation

• Use manufacturer‑approved reimaging or secure firmware processes; verify signatures and restore trusted boot settings.
• Apply patches and disable nonessential services; implement application allowlisting where supported.
• Reload a known‑good medication library and confirm accuracy with pharmacy before deployment.

Accounts and trust

• Rotate passwords, tokens, and certificates for pump management, integration, and maintenance accounts; remove unused or shared credentials.
• Renew device certificates and harden authentication to management systems.

Network and architecture

• Strengthen Network Segmentation with least‑privilege VLANs and microsegmentation; deny unnecessary east‑west and egress traffic by default.
• Tighten NAC enforcement, port security, and monitoring on all clinical network access points.

Validation and return to service

• Test devices offline, run self‑tests, verify time sync, and confirm event logging; then conduct a controlled clinical pilot.
• Obtain clinical sign‑off under Patient Safety Protocols before broad release; monitor post‑deployment telemetry.

Data and systems recovery

• Restore gateways and configuration from clean, offline backups; validate with hashes and database consistency checks.
• Confirm end‑to‑end data flows to the EHR and reconcile any backlog of device events.

Document Incident Actions

Thorough documentation demonstrates due diligence and accelerates future response. Capture what happened, why choices were made, and how to improve.

What to capture

• Timeline, roles, decisions, and clinical impacts; device identifiers and locations; technical steps and evidence collected.
• Chain‑of‑custody logs, hash manifests, storage locations, retention plans, and notification records.
• Operational metrics such as time to detect, isolate, and recover; ticket numbers with vendors and partners.

Continuous improvement

• Update playbooks and Incident Containment Strategies; tune detections and increase log retention where needed.
• Enhance zero‑trust controls, access hardening, and Network Segmentation; require stronger security assurances in supplier contracts.
• Conduct training and tabletop exercises; track MTTA/MTTC/MTTR to measure progress.

Prioritize patient safety, preserve trustworthy evidence, coordinate Regulatory Compliance Notifications, verify data integrity, and recover with hardened controls. Embedding these practices into Medical Device Cybersecurity reduces risk from future infusion pump ransomware events.

FAQs.

What are the initial steps in responding to infusion pump ransomware?

Stabilize patients and coordinate a safe therapy handoff, then isolate suspected pumps without erasing data. Build an accurate inventory of affected devices, preserve logs and screenshots, convene incident command, engage manufacturers and security partners, start any required notifications, and document every action and timestamp.

How can evidence be preserved during a data incident?

Photograph on‑device messages, export device and server logs to write‑once media, compute hashes, and maintain a strict chain of custody. Avoid resets or patches until collection is complete, capture relevant network telemetry, and—if vendor‑supported—perform forensic imaging. Use Data Integrity Verification to confirm what changed and when.

Which stakeholders must be notified in a ransomware attack?

Notify incident command, clinical engineering, security leadership, nursing and pharmacy leaders, privacy/legal, and communications. Externally, engage device manufacturers, service providers, insurance contacts, and appropriate law enforcement. Execute Regulatory Compliance Notifications to applicable regulators and contractual partners as required.

How is patient safety impacted by infusion pump ransomware?

Risks include therapy interruption, unintended rate changes, delayed medication administration, and unavailability of safe devices. Follow Patient Safety Protocols to prioritize clinical isolation and verification of delivered therapy, then return remediated devices to service only after clinical and technical validation.